The rise of Viagra initially sparked a period of growth for pharma, however recent changes present a murky outlook for investors. Off-patent versions are eroding profits, and ongoing patent challenges add additional https://rebeccadhpo323540.blogtov.com/21868719/sildenafil-and-big-pharma-a-risky-bet